These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 26573379)
1. Prognostic predictors of sudden sensorineural hearing loss in defibrinogenation therapy. Oya R; Horii A; Akazawa H; Osaki Y; Inohara H Acta Otolaryngol; 2016; 136(3):271-6. PubMed ID: 26573379 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of intratympanic corticosteroid, intravenous batroxobin and combined treatment for sudden sensorineural hearing loss with type-2 diabetes. Jia H; Yu Z; Li X; Wang J; Ge X; Chen ZT; Huang X; Wei Y Acta Otolaryngol; 2019 Jun; 139(6):522-528. PubMed ID: 31008670 [TBL] [Abstract][Full Text] [Related]
3. Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy. Suzuki H; Furukawa M; Kumagai M; Takahashi E; Matsuura K; Katori Y; Shimomura A; Kobayashi T Acta Otolaryngol; 2003 Jan; 123(1):46-50. PubMed ID: 12625572 [TBL] [Abstract][Full Text] [Related]
4. Sudden sensorineural hearing loss: is there a relationship between routine haematological parameters and audiogram shapes? Salvago P; Rizzo S; Bianco A; Martines F Int J Audiol; 2017 Mar; 56(3):148-153. PubMed ID: 27712131 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of systemic and intratympanic corticosteroid combination therapy versus intratympanic or systemic therapy in patients with idiopathic sudden sensorineural hearing loss: a randomized controlled trial. Ashtiani MK; Firouzi F; Bastaninejad S; Dabiri S; Nasirmohtaram S; Saeedi N; Ghazavi H; Sahebi L Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):89-97. PubMed ID: 29149379 [TBL] [Abstract][Full Text] [Related]
6. Serum Fibrinogen as a Prognostic Factor in Sudden Sensorineural Hearing Loss: A Meta-analysis. Oya R; Takenaka Y; Imai T; Sato T; Osaki Y; Ohta Y; Inohara H Otol Neurotol; 2018 Dec; 39(10):e929-e935. PubMed ID: 30303943 [TBL] [Abstract][Full Text] [Related]
7. Batroxobin can improve the efficacy of combination therapy for profound sudden sensorineural hearing loss greater than but not less than 100 dB HL. Jiang LZ; Zuo WQ J Laryngol Otol; 2024 Mar; 138(3):270-275. PubMed ID: 37994420 [TBL] [Abstract][Full Text] [Related]
8. Effect of combining batroxobin with acupuncture treatment on hearing recovery in patients with sudden sensorineural hearing loss. Le X; Liu J; Jia Q; Wu J; Jiang Y; Lv Z Acta Otolaryngol; 2024 Apr; 144(4):299-305. PubMed ID: 38953590 [TBL] [Abstract][Full Text] [Related]
9. Hearing recovery in sudden deafness patients using a modified defibrinogenation therapy. Shiraishi T; Kubo T; Okumura S; Naramura H; Nishimura M; Okusa M; Matsunaga T Acta Otolaryngol Suppl; 1993; 501():46-50. PubMed ID: 7680521 [TBL] [Abstract][Full Text] [Related]
10. The effect of initial treatment on hearing prognosis in idiopathic sudden sensorineural hearing loss: a nationwide survey in Japan. Okada M; Hato N; Nishio SY; Kitoh R; Ogawa K; Kanzaki S; Sone M; Fukuda S; Hara A; Ikezono T; Ishikawa K; Iwasaki S; Kaga K; Kakehata S; Matsubara A; Matsunaga T; Murata T; Naito Y; Nakagawa T; Nishizaki K; Noguchi Y; Sano H; Sato H; Suzuki M; Shojaku H; Takahashi H; Takeda H; Tono T; Yamashita H; Yamasoba T; Usami SI Acta Otolaryngol; 2017; 137(sup565):S30-S33. PubMed ID: 28359220 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of defibrinogenation and steroid therapies on sudden deafness. Kubo T; Matsunaga T; Asai H; Kawamoto K; Kusakari J; Nomura Y; Oda M; Yanagita N; Niwa H; Uemura T Arch Otolaryngol Head Neck Surg; 1988 Jun; 114(6):649-52. PubMed ID: 3284549 [TBL] [Abstract][Full Text] [Related]
13. Comparing the use of high dose to standard dose corticosteroids for the treatment of sudden sensorineural hearing loss in adults - A systematic review. Balai E; Gupta KK; Darr A; Jindal M Auris Nasus Larynx; 2024 Feb; 51(1):11-24. PubMed ID: 37127508 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of serum anti-heat-shock protein 70 and paraoxonase levels in idiopathic sudden sensorineural hearing loss. Düzer S; Alpay HC; Kaman D; Sakallıoğlu O; Yalçın S; Kaygusuz I; Karlıdağ T; Keleş E Kulak Burun Bogaz Ihtis Derg; 2014; 24(2):83-8. PubMed ID: 24835903 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy and intravenous steroids. Hosokawa S; Sugiyama K; Takahashi G; Takebayashi S; Mineta H J Laryngol Otol; 2017 Jan; 131(1):77-82. PubMed ID: 27917721 [TBL] [Abstract][Full Text] [Related]
16. Utility of anti-HSP 70, TNF-alpha, ESR, antinuclear antibody, and antiphospholipid antibodies in the diagnosis and treatment of sudden sensorineural hearing loss. Süslü N; Yilmaz T; Gürsel B Laryngoscope; 2009 Feb; 119(2):341-6. PubMed ID: 19160386 [TBL] [Abstract][Full Text] [Related]
17. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Choung YH; Park K; Shin YR; Cho MJ Laryngoscope; 2006 May; 116(5):747-52. PubMed ID: 16652082 [TBL] [Abstract][Full Text] [Related]
18. Sudden sensorineural hearing loss: have we got a cure? Panda NK; Verma RK; Saravanan K J Otolaryngol Head Neck Surg; 2008 Dec; 37(6):807-12. PubMed ID: 19128708 [TBL] [Abstract][Full Text] [Related]
19. Treatment of idiopathic sudden sensorineural hearing loss. Jeyakumar A; Francis D; Doerr T Acta Otolaryngol; 2006 Jul; 126(7):708-13. PubMed ID: 16803709 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy. Bae SC; Noh HI; Jun BC; Jeon EJ; Seo JH; Park SY; Kim JK; Lee DH; Oh JH; Park SN; Yeo SW Acta Otolaryngol; 2013 May; 133(5):428-33. PubMed ID: 23356871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]